Jeffrey J. Kraws

Jeffrey J. Kraws has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Flyte Aviation, Inc. and Theriva Biologics, Inc. We count 8 filings; the first trade dates from 14 March 2017 and the latest from 20 November 2020.

In open-market terms, that means 2 purchases worth €7,175 on one side and 2 sales worth €80k on the other. Netting one side against the other leaves €73k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants and 1 option exercise. So far in 2020, the count stands at 2 purchases and no sales.

The record was last updated on 24 November 2020 with a share grant (€915) in Flyte Aviation, Inc. The latest purchase dates back some time: it was published 2,270 days ago, on 5 August 2020. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.